# Cross-Domain Lifecycle Evidence Collection — Healthcare + Logistics
**Phase:** Evidence Collection (Rule-of-Three Validation)  
**Date:** 2026-09-09  
**Status:** `EVIDENCE COLLECTED` — Ready for Semantic Comparison  

---

## Executive Summary

**Objective:** Validate Universal Lifecycle hypothesis by collecting concrete evidence from Healthcare Kernel (H1-H12) and Logistics Kernel (E7.1-E7.3).

**Evidence Quality:** HIGH — Both kernels provide production-validated lifecycle patterns with comprehensive test coverage:
- Healthcare: 52 test suites
- Logistics: 547 tests (E7.1: 366, E7.2: 73, E7.3: 108)

**Key Finding:** Both Healthcare and Logistics implement **multiple independent lifecycle patterns** with shared operational semantics but domain-specific states and business rules.

---

## Healthcare Kernel — Lifecycle Evidence

### Lifecycle H1: Encounter Status

**Entity:** Encounter (Patient visit/episode)

**State Representation:** Enum type `EncounterStatus`

**States:**
- `planned` — Scheduled but not started
- `arrived` — Patient checked in
- `triaged` — Initial assessment complete
- `in-progress` — Active treatment
- `on-hold` — Temporarily suspended
- `finished` — Completed normally
- `cancelled` — Cancelled

**Example Transitions:**
```
planned → arrived → triaged → in-progress → finished
planned → cancelled
in-progress → on-hold → in-progress
```

**Forbidden Transitions:**
- `finished` → * (terminal state)
- `cancelled` → * (terminal state)

**Guards/Preconditions:**
- Cannot modify finished/cancelled encounters
- Triage required before in-progress (clinical workflow rule)

**Actor/Ownership:**
- Each transition requires practitioner/nurse identity
- Audit trail: createdAt, updatedAt

**Evidence Requirements:**
- Timestamps for key transitions (arrivedAt, triagedAt, finishedAt)
- Practitioner identity for clinical transitions

**Side Effects:**
- `finished` status triggers billing finalization
- `cancelled` status releases bed/resource assignments

**Implementation Location:**
- Types: `src/platform/healthcare/shared-kernel/types.ts` lines 85-92
- Domain logic: Distributed across H2 Encounter Engine, H3 Order Engine

**Semantic Notes:**
- This is a **clinical episode lifecycle**
- Two terminal states: finished (success), cancelled (cancelled)
- Linear progression with hold state for exceptions
- Encounter is the **aggregate root** for Orders, Vitals, Medications

---

### Lifecycle H2: Clinical Order Status

**Entity:** ClinicalOrder (Lab, Imaging, Medication, Procedure orders)

**State Representation:** Enum type `OrderStatus`

**States:**
- `PENDING` — Created, awaiting CDS check
- `VALIDATED` — CDS check passed/warned
- `REJECTED` — CDS check blocked
- `APPROVED` — Physician signed off
- `ACTIVE` — Ready for fulfillment
- `COMPLETED` — Fulfilled
- `DISCONTINUED` — Cancelled by physician

**Example Transitions:**
```
PENDING → VALIDATED → APPROVED → ACTIVE → COMPLETED
PENDING → REJECTED (terminal)
APPROVED → DISCONTINUED
ACTIVE → DISCONTINUED
```

**Forbidden Transitions:**
- `COMPLETED` → * (terminal state)
- `REJECTED` → * (terminal state)
- `DISCONTINUED` → * (terminal state)
- Cannot transition from terminal states

**Guards/Preconditions:**
- **PENDING → VALIDATED:** CDS check must pass or warn (H8 integration)
- **PENDING → REJECTED:** CDS check blocked
- **VALIDATED → APPROVED:** Physician authorization required
- **APPROVED → ACTIVE:** No clinical holds
- **ACTIVE → COMPLETED:** Order fulfilled
- **APPROVED/ACTIVE → DISCONTINUED:** Physician cancellation only

**Actor/Ownership:**
- `orderedBy` (physician placing order)
- CDS check performed by H8 engine
- Approval requires physician role
- Discontinuation requires physician authorization

**Evidence Requirements:**
- CDS check status + alert count (H8 evidence)
- Physician signature for approval
- Fulfillment evidence for completion
- Discontinuation reason + physician identity

**Side Effects:**
- `VALIDATED` → triggers downstream workflows (pharmacy, lab, imaging)
- `ACTIVE` → enables fulfillment (Order released to executing department)
- `COMPLETED` → billing event, clinical record update
- `DISCONTINUED` → cancels downstream workflows, releases resources

**Persistence Model:**
- Status stored as enum in database
- State machine enforced in `clinical-order.entity.ts` domain layer
- CDS check results linked from H8 engine

**Implementation Location:**
- Domain: `src/platform/healthcare/engines/order-engine/domain/clinical-order.entity.ts`
  - State transitions: lines 227-350
  - Guards: validate() lines 237-249, reject() lines 258-272, approve() lines 278-296, activate() lines 306-313, complete() lines 322-328, discontinue() lines 333-354
- Types: `src/platform/healthcare/shared-kernel/types.ts` lines 193-201
- Tests: `src/platform/healthcare/engines/order-engine/domain/__tests__/clinical-order.entity.test.ts` (130+ tests)

**Semantic Notes:**
- **Approval workflow lifecycle** with CDS safety gates
- **Three terminal states:** COMPLETED (success), REJECTED (blocked), DISCONTINUED (cancelled)
- **H8 CDS Engine integration:** PENDING → VALIDATED/REJECTED decision made by H8
- **Physician-gated transitions:** Approval and discontinuation require physician role
- Order is **child aggregate of Encounter** (cannot exist without Encounter)
- This is a **regulated clinical workflow** with safety/compliance gates

---

### Lifecycle H3: Medication Order Status

**Entity:** MedicationOrder

**State Representation:** Enum type `MedicationOrderStatus`

**States:**
- `draft` — Created but not finalized
- `active` — Active prescription
- `on-hold` — Temporarily suspended
- `completed` — Treatment finished
- `cancelled` — Cancelled before completion
- `stopped` — Discontinued by physician

**Example Transitions:**
```
draft → active → completed
draft → cancelled
active → on-hold → active
active → stopped
```

**Forbidden Transitions:**
- `completed` → * (terminal state)
- `cancelled` → * (terminal state)
- `stopped` → * (terminal state)

**Guards/Preconditions:**
- `draft → active`: Prescription verification required
- `active → stopped`: Physician order required

**Actor/Ownership:**
- `prescribedBy` (physician)
- `dispensedBy` (pharmacist)

**Evidence Requirements:**
- Prescription signature
- Dispensing record
- Stop order documentation

**Side Effects:**
- `active` → pharmacy dispense workflow
- `completed` → medication administration record (MAR) closure
- `stopped` → alerts nursing, updates MAR

**Implementation Location:**
- Types: `src/platform/healthcare/shared-kernel/types.ts` lines 279-286
- Domain: Likely in H4 Pharmacy Engine

**Semantic Notes:**
- Similar to Order lifecycle but medication-specific
- Multiple terminal states
- Integrates with MAR (Medication Administration Record)

---

### Lifecycle H4: Surgical Case Status

**Entity:** SurgicalCase (OR procedure)

**State Representation:** Enum type `SurgicalCaseStatus`

**States:**
- `SCHEDULED` — Planned but not started
- `PREOP_READY` — Pre-op checklist complete
- `ANESTHETIZED` — Anesthesia administered
- `PROCEDURE_IN_PROGRESS` — Surgery underway
- `RECOVERY_PACU` — Post-anesthesia recovery
- `POSTOP_COMPLETED` — Case closed (terminal)

**Example Transitions:**
```
SCHEDULED → PREOP_READY → ANESTHETIZED → PROCEDURE_IN_PROGRESS → RECOVERY_PACU → POSTOP_COMPLETED
```

**Forbidden Transitions:**
- `POSTOP_COMPLETED` → * (terminal state)
- Cannot skip states (linear progression enforced)

**Guards/Preconditions (Safety Gates):**
- **SCHEDULED → PREOP_READY:** Pre-op checklist complete
- **PREOP_READY → ANESTHETIZED:** 
  - Anesthesia consent signed (HARD BLOCK)
  - Cannot proceed without consent
- **ANESTHETIZED → PROCEDURE_IN_PROGRESS:**
  - Sign In checklist complete (WHO Surgical Safety Checklist)
  - Time Out checklist complete (WHO Surgical Safety Checklist)
  - CSSD sterilization token verified (optional but enforced if required)
- **PROCEDURE_IN_PROGRESS → RECOVERY_PACU:** No explicit guard
- **RECOVERY_PACU → POSTOP_COMPLETED:** Sign Out checklist complete (WHO Surgical Safety Checklist)

**Actor/Ownership:**
- `surgeonId` (operating surgeon)
- Checklist completion tracked per step (signinCompletedBy, timeoutCompletedBy, signoutCompletedBy)
- Anesthesia consent requires patient/guardian signature

**Evidence Requirements:**
- Pre-op checklist evidence
- Anesthesia consent document
- WHO Surgical Safety Checklist evidence:
  - Sign In completion (timestamp + actor)
  - Time Out completion (timestamp + actor)
  - Sign Out completion (timestamp + actor)
- CSSD sterilization token (if equipment sterilization required)

**Side Effects:**
- `ANESTHETIZED` → triggers OR resource allocation
- `PROCEDURE_IN_PROGRESS` → OR time tracking starts
- `POSTOP_COMPLETED` → releases OR, releases Surgeon exclusion, triggers billing

**Persistence Model:**
- Status stored as enum
- State machine enforced in `surgical-case.entity.ts` domain layer
- Checklist states stored separately (signinCompleted, timeoutCompleted, signoutCompleted)
- Version tracking for optimistic concurrency control

**Implementation Location:**
- Domain: `src/platform/healthcare/engines/surgical-engine/domain/surgical-case.entity.ts`
  - State machine: lines 10-16 (enum), lines 160-261 (transitions)
  - Safety gates: completePreop() line 161, administerAnesthesia() line 180, startProcedure() line 197, transferToPacu() line 228, completeCase() line 237
- Repository: `src/platform/healthcare/engines/surgical-engine/repositories/supabase-surgery.repository.ts`
- Tests: `src/platform/healthcare/engines/surgical-engine/domain/__tests__/surgical-case.entity.test.ts`

**Semantic Notes:**
- **Safety-critical lifecycle** with WHO Surgical Safety Checklist integration
- **Linear progression enforced** (cannot skip states)
- **Hard safety blocks:**
  - Anesthesia consent required (ANESTHETIZED gate)
  - WHO checklists required (PROCEDURE_IN_PROGRESS and POSTOP_COMPLETED gates)
  - CSSD sterilization token (optional but enforced if enabled)
- **One terminal state:** POSTOP_COMPLETED
- **Aggregate root** with embedded safety checklist state
- This is the **most safety-regulated lifecycle** in Healthcare Kernel

---

### Lifecycle H5: Prescription Status (Pharmacy Engine)

**Entity:** Prescription (Pharmacy workflow)

**State Representation:** Enum type `PrescriptionStatus`

**States:**
- `PENDING_VERIFICATION` — Created, awaiting pharmacist review
- `VERIFIED` — Pharmacist verified, ready to dispense
- `DISPENSED` — Medication dispensed
- `MAR_READY` — Ready for nurse administration
- `REJECTED` — Pharmacist rejected
- `ON_HOLD` — Temporarily suspended
- `CANCELLED` — Cancelled

**Example Transitions:**
```
PENDING_VERIFICATION → VERIFIED → DISPENSED → MAR_READY
PENDING_VERIFICATION → REJECTED (terminal)
VERIFIED → ON_HOLD → VERIFIED
```

**Forbidden Transitions:**
- `REJECTED` → * (terminal state)
- `CANCELLED` → * (terminal state)
- `MAR_READY` → * (terminal state — MAR workflow takes over)
- Cannot transition from terminal states

**Guards/Preconditions:**
- **PENDING_VERIFICATION → VERIFIED:**
  - Drug interaction screening passed (safety check)
  - Allergy screening passed (safety check)
  - Pharmacist verification signature required
  - If high-alert drug: dual verification required (two pharmacists)
- **PENDING_VERIFICATION → REJECTED:**
  - Safety screening failed (contraindication detected)
- **VERIFIED → DISPENSED:**
  - Stock availability checked
  - Dispensing actor required
- **DISPENSED → MAR_READY:**
  - Medication delivered to ward/unit
  - MAR system notified

**Actor/Ownership:**
- Prescriber (physician)
- Pharmacist verifier (primary)
- Second pharmacist verifier (if high-alert drug)
- Dispenser (pharmacy technician or pharmacist)

**Evidence Requirements:**
- Safety screening results (drug interactions, allergies)
- Pharmacist verification signature + timestamp
- Dual verification signatures (if high-alert)
- Dispensing record (timestamp + actor + quantity)
- Override audit trail (if safety warnings overridden)

**Side Effects:**
- `VERIFIED` → stock reservation
- `DISPENSED` → stock deduction, inventory update
- `MAR_READY` → notification to nursing, MAR system activated
- `REJECTED` → physician notification, alternative prescription suggested

**Persistence Model:**
- Status stored as enum
- Safety state tracked separately (`SafetyState`: NO_BLOCK / OVERRIDE_REQUIRED / ACKNOWLEDGED / BLOCKED)
- Dual verification state tracked separately (`DualVerificationState`: NONE / HIGH_ALERT / VERIFICATION_1 / DUAL_VERIFIED)
- Override audit history stored (warningCode, decision, rationale, practitionerId, timestamp)

**Implementation Location:**
- Domain: `src/platform/healthcare/engines/pharmacy-engine/domain/prescription.entity.ts`
  - States: lines 24-32 (PrescriptionStatus enum)
  - Safety states: lines 34-36
  - State transitions: lines 245-380
  - Guards: verify() lines 249-330, reject() lines 337-353, dispense() lines 355-368, markMarReady() lines 371-379
- Service: `src/platform/healthcare/engines/pharmacy-engine/pharmacy-engine.service.ts`
- Tests: `src/platform/healthcare/engines/pharmacy-engine/domain/__tests__/prescription.entity.test.ts` (line 174: "transition through verify -> dispense -> mar_ready")

**Semantic Notes:**
- **Safety-critical pharmacy workflow lifecycle**
- **Parallel state machines:**
  - Primary: PrescriptionStatus (workflow state)
  - Safety: SafetyState (safety screening state)
  - Verification: DualVerificationState (high-alert drug verification)
- **Terminal states:** REJECTED (safety block), CANCELLED (cancelled), MAR_READY (handoff to nursing)
- **High-alert drug special handling:** Requires dual verification (two pharmacist signatures)
- **Override audit trail:** All safety overrides logged with rationale + practitioner identity
- Integrates with **H8 CDS Engine** for drug interaction screening

---

### Lifecycle H6: Governed Rule Status (Rule Engine H10)

**Entity:** GovernedRule (Clinical decision support rules, policies)

**State Representation:** Enum type `RuleStatus` (inferred from code)

**States:**
- `DRAFT` — Authored but not reviewed
- `PENDING_REVIEW` — Submitted for review
- `ACTIVE` — Approved and enforced
- `SUPERSEDED` — Replaced by newer version (terminal)

**Example Transitions:**
```
DRAFT → PENDING_REVIEW → ACTIVE → SUPERSEDED
DRAFT → ACTIVE (fast-track approval)
```

**Forbidden Transitions:**
- `SUPERSEDED` → * (terminal state)
- Cannot modify ACTIVE rules (must supersede with new version)

**Guards/Preconditions:**
- **DRAFT → PENDING_REVIEW:** Reviewer assignment required
- **DRAFT/PENDING_REVIEW → ACTIVE:**
  - Approver role authorization check
  - If rule severity is CRITICAL or enforcement is BLOCK/ABSOLUTE_BLOCK:
    - Requires chief_of_department or medical_director role (elevated authorization)
  - Approval evidence required
  - Effective date range validation
- **ACTIVE → SUPERSEDED:**
  - Only ACTIVE rules can be superseded
  - Effective-to date set (end of validity period)

**Actor/Ownership:**
- `authorId` (rule creator)
- `reviewerId` (reviewer)
- `approverId` (approver)
- `approverRole` (role-based authorization)

**Evidence Requirements:**
- Approval evidence (record of approval decision + rationale)
- Canonical artifact checksum (Lock 3 — tamper detection)
- Effective date range (effectiveFrom, effectiveTo)
- Approver role verification (chief vs. medical director for critical rules)

**Side Effects:**
- `ACTIVE` → rule enforced in H8 CDS checks
- `SUPERSEDED` → rule removed from active enforcement, archived for audit

**Persistence Model:**
- Status stored as enum
- Artifact integrity protected by canonical checksum (Lock 3)
- Version controlled (ruleCode + ruleVersion)

**Implementation Location:**
- Domain: `src/platform/healthcare/engines/rule-engine/domain/governed-rule.entity.ts`
  - State transitions: lines 102-134
  - Guards: submitForReview() line 102, approveAndActivate() line 110, supersede() line 128
- Types: Inferred from implementation (DRAFT | PENDING_REVIEW | ACTIVE | SUPERSEDED)

**Semantic Notes:**
- **Governance lifecycle** for clinical rules/policies
- **Role-based authorization gates:** Critical rules require elevated approval (chief/director)
- **One terminal state:** SUPERSEDED (replaced by newer version)
- **Immutability after activation:** Cannot modify ACTIVE rules, must supersede
- **Artifact integrity:** Canonical checksum prevents tampering (Lock 3)
- **Jurisdiction-aware:** Rules can be jurisdiction-specific (LOCAL, STATE, FEDERAL)
- This is a **governance/compliance lifecycle**

---

### Lifecycle H7: Bed Status

**Entity:** Bed (Hospital bed management)

**State Representation:** Enum type `BedStatus`

**States:**
- `available` — Ready for assignment
- `occupied` — Patient assigned
- `reserved` — Reserved for incoming patient
- `cleaning` — Post-discharge cleaning
- `maintenance` — Under repair
- `out-of-service` — Permanently unavailable

**Example Transitions:**
```
available → reserved → occupied → cleaning → available
available → maintenance → available
available → out-of-service (terminal)
```

**Forbidden Transitions:**
- `out-of-service` → * (terminal state)

**Guards/Preconditions:**
- `available → occupied`: Patient assignment required
- `occupied → cleaning`: Patient discharge required

**Actor/Ownership:**
- Ward nurse (bed assignment)
- Housekeeping (cleaning transitions)
- Facilities (maintenance transitions)

**Evidence Requirements:**
- Patient assignment record
- Discharge timestamp
- Cleaning completion record

**Side Effects:**
- `occupied` → capacity tracking update
- `available` → bed available for admission
- `out-of-service` → reduces ward capacity

**Implementation Location:**
- Types: `src/platform/healthcare/shared-kernel/types.ts` lines 322-329
- Domain logic: Likely in H5 Bed Management Engine

**Semantic Notes:**
- **Resource management lifecycle**
- One terminal state: out-of-service
- Integrates with ward capacity tracking

---

## Logistics Kernel — Lifecycle Evidence

*[This section contains the complete Logistics evidence from the sub-agent report — already captured in detail above. Key lifecycles include:]*

1. **Item/SKU Status** (E7.1 Domain)
2. **Location Status** (E7.1 + E7.2 Operations)
3. **Inventory Status** (E7.1 + E7.2 Operations) — Most complex with 8 states
4. **Movement Status** (E7.1 Domain)
5. **Traceability Recall Status** (E7.3 Rules)
6. **Traceability Compliance Status** (E7.3 Rules)
7. **Warehouse Receipt Status** (Product/Operational Layer)
8. **Freight Invoice Status** (Product/Operational Layer)
9. **Shipment Status** (Product/Operational Layer)
10. **Route Status** (Product/Operational Layer)

*[Full Logistics evidence already documented in sub-agent output — see context above]*

---

## Cross-Domain Semantic Comparison

### Shared Operational Semantics (HIGH CONFIDENCE)

Both Healthcare and Logistics lifecycles share these patterns:

| Pattern | Healthcare Examples | Logistics Examples |
|---------|-------------------|-------------------|
| **Discrete states** | Encounter: planned/arrived/triaged/in-progress/finished | Item: PENDING/ACTIVE/INACTIVE/DISCONTINUED |
| **Directed transitions** | Order: PENDING→VALIDATED→APPROVED→ACTIVE→COMPLETED | Movement: PENDING→COMPLETED |
| **Terminal states** | Order: COMPLETED, REJECTED, DISCONTINUED | Item: DISCONTINUED, Movement: COMPLETED/CANCELLED/FAILED |
| **Guard conditions** | Surgical: Anesthesia consent required before ANESTHETIZED | Inventory: Must be AVAILABLE to reserve |
| **Actor constraints** | Prescription: Pharmacist verification required | Location: E7.2 deactivation requires deactivatedBy |
| **Evidence requirements** | Surgical: WHO checklist evidence | Location: E7.2 deactivation requires reason |
| **Audit trail** | All entities: createdAt, updatedAt, actor fields | All entities: createdAt, updatedAt, actor fields |
| **Side effects** | Order ACTIVE → triggers fulfillment | Movement COMPLETED → updates inventory |
| **Approval workflows** | Order: VALIDATED→APPROVED (physician sign-off) | Movement: PENDING→COMPLETED (approval) |
| **Safety gates** | Surgical: Anesthesia consent HARD BLOCK | Inventory: Cannot reserve non-AVAILABLE inventory |

### Domain-Specific Differences (SEMANTIC DIVERGENCE)

| Aspect | Healthcare | Logistics |
|--------|-----------|-----------|
| **State names** | ANESTHETIZED, TRIAGED, MAR_READY | QUARANTINE, TRANSIT, PENDING_PUTAWAY |
| **Lifecycle purpose** | Clinical safety, patient care | Inventory accuracy, supply chain |
| **Compliance context** | Clinical safety, HIPAA, medical liability | Regulatory traceability (FDA, EU), quality control |
| **Terminal state semantics** | COMPLETED (treatment done), DISCONTINUED (cancelled by physician) | DISCONTINUED (product obsolete), EXPIRED (regulatory) |
| **Approval authority** | Physician, Pharmacist (licensed professionals) | Warehouse manager, Approver (operational roles) |
| **Safety criticality** | Life-critical (anesthesia consent, drug interactions) | Quality-critical (expiry, recalls) |
| **Quantity coupling** | Not quantity-aware (focus on clinical state) | Quantity-aware (Inventory: reserved + available = on_hand) |
| **Immutability patterns** | Orders can be discontinued but not deleted | Movements are immutable after COMPLETED |

---

## Rule-of-Three Validation

### ✅ PATTERN CONFIRMED: State Machine Primitive

**Evidence:**
- **Healthcare:** 7 distinct lifecycles identified (Encounter, Order, MedicationOrder, SurgicalCase, Prescription, GovernedRule, Bed)
- **Logistics:** 10 distinct lifecycles identified (Item, Location, Inventory, Movement, Traceability Recall, Traceability Compliance, Receipt, Invoice, Shipment, Route)
- **Preschool (from discovery):** 4+ lifecycles (Admission, Medication, Maintenance, Consent)

**Total:** 21+ independent lifecycle implementations across 3 domains

**Semantic Overlap:**
- All use discrete enum states
- All enforce directed transitions (state A → state B)
- All have guard conditions (preconditions for transitions)
- All track actor/timestamp (audit trail)
- All have terminal states (no outbound transitions)

**Verdict:** ✅ **STRONG MATCH** — State machine pattern is universal

---

### ✅ PATTERN CONFIRMED: Terminal States

**Evidence:**
- **Healthcare:** COMPLETED, REJECTED, DISCONTINUED, POSTOP_COMPLETED, CANCELLED, SUPERSEDED
- **Logistics:** DISCONTINUED, COMPLETED, CANCELLED, FAILED, EXPIRED, DAMAGED, DESTROYED, paid, delivered
- **Preschool:** CLOSED (maintenance), CONSENTED (consent)

**Semantic Overlap:**
- Terminal states represent "no further transitions"
- Success terminals (COMPLETED, POSTOP_COMPLETED, delivered)
- Failure terminals (REJECTED, CANCELLED, EXPIRED)
- Regulatory terminals (DESTROYED, SUPERSEDED)

**Verdict:** ✅ **STRONG MATCH** — Terminal state concept is universal

---

### ✅ PATTERN CONFIRMED: Actor + Evidence Requirements

**Evidence:**
- **Healthcare E7.2-style pattern:**
  - Surgical: signinCompletedBy, timeoutCompletedBy, signoutCompletedBy
  - Prescription: pharmacist verification signature
  - Order: orderedBy (physician), CDS check evidence
  - GovernedRule: approverId + approverRole + approvalEvidence
- **Logistics E7.2 pattern:**
  - Location: deactivatedBy + reason, reactivatedBy + reason, closedBy + reason
  - Inventory: requestedBy + reason (reserve operation)
  - Receipt: submitted_by, completed_by, held_by
  - Invoice: approved_by + approved_at + approved_amount

**Semantic Overlap:**
- Actor identity required for critical transitions
- Reason/rationale required for non-routine transitions
- Timestamp tracking (actorAt pattern)
- Evidence chain for audit/compliance

**Verdict:** ✅ **STRONG MATCH** — Actor + evidence pattern repeats across domains

---

### ⚠️ PARTIAL MATCH: Approval Workflows

**Evidence:**
- **Healthcare:** Order (VALIDATED→APPROVED), GovernedRule (PENDING_REVIEW→ACTIVE)
- **Logistics:** Movement (PENDING→COMPLETED), Invoice (pending_approval→approved)
- **Not universal:** Item, Location, Inventory, Traceability do NOT have approval workflows

**Semantic Overlap:**
- Multi-actor approval process exists
- PENDING → APPROVED pattern
- Rejection path exists (PENDING → REJECTED)

**Domain Differences:**
- Healthcare approval is **role-based authorization** (physician, chief of department)
- Logistics approval is **operational sign-off** (warehouse manager)

**Verdict:** ⚠️ **PARTIAL MATCH** — Approval workflows exist but are not universal. Should be **optional feature**, not core primitive.

---

### ❌ PATTERN DIVERGENCE: Quantity-Aware Lifecycles

**Evidence:**
- **Logistics Inventory:** Status coupled with quantity (RESERVED = quantityReserved > 0)
- **Healthcare:** No quantity-aware lifecycles (focus on clinical state, not inventory count)

**Verdict:** ❌ **NO MATCH** — Quantity-aware lifecycle is **Logistics-specific**, not general pattern.

---

### ❌ PATTERN DIVERGENCE: Immutable Transaction Logs

**Evidence:**
- **Logistics Movement:** COMPLETED status makes entity immutable (cannot be modified)
- **Healthcare:** Orders can be discontinued, Prescriptions can be stopped (not immutable)

**Verdict:** ❌ **NO MATCH** — Immutability pattern is **domain-specific design choice**, not universal.

---

### ⚠️ PARTIAL MATCH: Parallel State Machines

**Evidence:**
- **Healthcare Prescription:** 3 parallel states (PrescriptionStatus, SafetyState, DualVerificationState)
- **Logistics Traceability:** 2 parallel states (RecallStatus, ComplianceStatus)

**Semantic Overlap:**
- Multiple orthogonal concerns tracked via separate state machines
- Guard relationships between state machines (e.g., cannot be COMPLIANT if RECALLED)

**Domain Differences:**
- Healthcare uses parallel states for **safety gates** (SafetyState blocks dispensing)
- Logistics uses parallel states for **regulatory compliance** (RecallStatus + ComplianceStatus)

**Verdict:** ⚠️ **PARTIAL MATCH** — Parallel state machines exist but are not universal. Should be **optional composition**, not core primitive.

---

## Abstraction Justification Analysis

### What CAN Be Abstracted (High Confidence)

| Primitive | Healthcare Evidence | Logistics Evidence | Justification |
|-----------|-------------------|-------------------|---------------|
| **State Machine Core** | 7 lifecycles | 10 lifecycles | All use discrete states + transitions + guards |
| **Terminal State Concept** | COMPLETED, REJECTED, etc. | DISCONTINUED, EXPIRED, etc. | Universal pattern across 17+ lifecycles |
| **Guard Conditions** | Anesthesia consent, CDS check | AVAILABLE status, quantity check | Universal precondition pattern |
| **Actor + Timestamp** | All entities | All entities (E7.2 especially) | Universal audit trail pattern |
| **Evidence Requirements** | WHO checklist, CDS results | Reason strings, sterilization tokens | Universal compliance pattern |

### What CANNOT Be Abstracted (High Risk)

| Pattern | Why NOT Universal |
|---------|------------------|
| **State names** | ANESTHETIZED vs. QUARANTINE — domain semantics differ |
| **Transition rules** | Healthcare: linear safety progression, Logistics: flexible operational flow |
| **Side effects** | Order → billing (Healthcare) vs. Movement → inventory (Logistics) — domain-specific logic |
| **Quantity coupling** | Only Logistics Inventory needs quantity-aware state |
| **Immutability** | Only Logistics Movement is immutable after COMPLETED |
| **Approval workflows** | Not universal (Item, Location, Inventory have no approval) |

---

## Duplication Cost Analysis

### Current Duplication

**Healthcare:**
- 7 lifecycles × ~100-150 LOC per lifecycle = **700-1050 LOC** (state machine + guards)

**Logistics:**
- 10 lifecycles × ~100-200 LOC per lifecycle = **1000-2000 LOC** (state machine + guards + E7.2 operations)

**Preschool (projected):**
- 4-6 lifecycles × ~100-150 LOC per lifecycle = **400-900 LOC**

**Total Duplication:** ~**2100-3950 LOC** (state machine logic + guards + audit)

### Abstraction Cost Estimate

**Abstraction Implementation:**
- Lifecycle primitive definition: ~200-300 LOC
- Generic state machine engine: ~300-500 LOC
- Guard/transition framework: ~200-300 LOC
- Actor/evidence tracking: ~100-200 LOC
- Test coverage: ~500-800 LOC
- Documentation + migration guide: ~effort equivalent to 200 LOC

**Total Abstraction Cost:** ~**1500-2300 LOC + migration effort**

### Cost-Benefit Analysis

**Benefits:**
- **Eliminates ~2100-3950 LOC** of duplicated state machine logic
- **Standardizes lifecycle semantics** across all domains
- **Reduces testing burden** (test primitive once, reuse everywhere)
- **Improves maintainability** (single source of truth for lifecycle behavior)

**Costs:**
- **Upfront abstraction design + implementation:** ~1500-2300 LOC
- **Migration effort:** Refactor existing 17+ lifecycles to use primitive
- **Learning curve:** Teams must learn new abstraction
- **Risk of over-abstraction:** If primitive too rigid, domains cannot express semantics

**Break-Even Point:** If Bella adds ≥2 more domains (Real Estate, Automotive), total lifecycle count reaches ~25-30, making abstraction clearly justified.

**Current Recommendation:** ⚠️ **ABSTRACTION LIKELY JUSTIFIED** but requires **Phase 3: Migration Feasibility Assessment** before proceeding.

---

## Migration Feasibility Assessment (Gate 5)

### Can Healthcare Lifecycles Migrate?

**Low-Risk Migrations:**
- ✅ **Encounter Status:** Simple enum state machine, no complex side effects
- ✅ **Bed Status:** Simple resource management lifecycle
- ✅ **GovernedRule Status:** Governance lifecycle, approval workflow well-defined

**Medium-Risk Migrations:**
- ⚠️ **Clinical Order Status:** Integrates with H8 CDS engine, CDS check must remain decoupled
- ⚠️ **Medication Order Status:** Integrates with pharmacy stock, MAR system

**High-Risk Migrations:**
- 🔴 **Surgical Case Status:** Safety-critical with WHO checklist gates, anesthesia consent HARD BLOCKS
  - Risk: Abstraction must not weaken safety gates
  - Mitigation: Safety guards must be first-class primitive feature
- 🔴 **Prescription Status:** Parallel state machines (PrescriptionStatus + SafetyState + DualVerificationState)
  - Risk: Primitive must support parallel state composition
  - Mitigation: Abstraction must support orthogonal state machines

### Can Logistics Lifecycles Migrate?

**Low-Risk Migrations:**
- ✅ **Item Status:** Simple enum state machine
- ✅ **Location Status:** E7.1 + E7.2 pattern well-defined
- ✅ **Movement Status:** Immutability can be modeled as "terminal state + no modification allowed"

**Medium-Risk Migrations:**
- ⚠️ **Traceability (Recall + Compliance):** Parallel state machines, guard relationships
- ⚠️ **Warehouse Receipt Status:** Operational workflow, inventory coupling

**High-Risk Migrations:**
- 🔴 **Inventory Status:** Quantity-aware lifecycle (status coupled with quantityReserved, quantityAvailable)
  - Risk: Abstraction must support quantity-aware state transitions
  - Mitigation: Quantity tracking may need to remain domain-specific

### Migration Verdict

**Gate 5 Assessment:** ⚠️ **MIGRATION FEASIBLE WITH CONDITIONS**

**Conditions:**
1. **Safety-critical guards must be preserved:** Surgical anesthesia consent, WHO checklists cannot be weakened
2. **Parallel state machines must be supported:** Prescription (3 states), Traceability (2 states)
3. **Quantity-aware lifecycles may need domain-specific extension:** Inventory status
4. **Side effects must remain domain-specific:** Abstraction provides lifecycle skeleton, domains implement side effects
5. **Actor/evidence requirements must be first-class:** Not bolt-on, but core primitive feature

---

## Promotion Gate Scorecard

| Gate | Criteria | Evidence | Score |
|------|----------|----------|-------|
| **G1: Domain Coverage** | ≥3 independent domains | Healthcare (7), Logistics (10), Preschool (4+) = **3 domains, 21+ lifecycles** | ✅ **PASS** |
| **G2: Semantic Overlap** | Core invariants match | State machine, terminal states, guards, actor/evidence, audit trail | ✅ **PASS** |
| **G3: Real Duplication** | Code is being duplicated | ~2100-3950 LOC duplicated across 17+ lifecycles | ✅ **PASS** |
| **G4: Cost Justified** | Abstraction cost < duplication cost | Rough estimates exist but NOT PROVEN. Requires abstraction design first. | ⏳ **PENDING** |
| **G5: Migration Feasible** | Can migrate without semantic loss or high regression risk | Risks identified (safety gates, parallel states, quantity-aware) but NO CONCRETE MIGRATION PATH validated. | ⏳ **PENDING** |

**Overall Verdict:** ⏳ **RULE-OF-THREE VALIDATED — G4/G5 PENDING**

**NOT eligible for ADR until G4 (cost analysis) and G5 (migration feasibility) are proven with concrete evidence.**

---

## Next Steps

### Phase 2: Minimum Common Kernel Exploration (Bounded)

**Objective:** Identify the **smallest possible abstraction** that can represent Healthcare, Logistics, and Preschool lifecycle semantics WITHOUT embedding domain-specific logic.

**Critical Principle:**
> **Universal Lifecycle must never become a weaker execution path around an existing domain invariant.**

If Surgical Case currently BLOCKS without anesthesia consent, abstraction must preserve that block strength. Safety guards cannot become optional callbacks.

**Adversarial Test Cases (Falsification):**
1. **Surgical Case (Healthcare):** Safety-critical guards (anesthesia consent, WHO checklists) must remain HARD BLOCKS
2. **Prescription (Healthcare):** Parallel state machines (PrescriptionStatus + SafetyState + DualVerificationState) must be composable
3. **Inventory (Logistics):** Quantity-aware lifecycle (status coupled with quantityReserved, quantityAvailable) must not force quantity into core abstraction

**Success Criteria:**
- Kernel can express all 3 adversarial cases WITHOUT domain-specific hacks
- Domain semantics remain in domain layer (not leaked into abstraction)
- Safety-critical guards remain enforceable with same strength
- Quantity coupling remains domain-specific (not forced into kernel)

**Hypothesis for Minimum Kernel:**
```typescript
Lifecycle Definition
├── State (domain-defined enum)
├── Transition (A → B, domain-defined rules)
├── Guard (precondition check, domain-implemented)
├── Actor / Authority (who can trigger, domain-defined)
├── Evidence Requirement (what proof needed, domain-defined)
├── Side Effect Hook (domain-implemented callback)
└── Audit Event (standard provenance tracking)
```

**Deliverables:**
1. Kernel interface sketch (TypeScript pseudocode, ~50-100 LOC)
2. Surgical Case mapping (show how safety guards map to kernel)
3. Prescription mapping (show how parallel states compose)
4. Inventory mapping (show how quantity stays domain-specific)
5. Falsification result (PASS = kernel is valid, FAIL = kernel too rigid or too leaky)

**If Phase 2 succeeds → Phase 3: Cost Analysis (G4)**  
**If Phase 2 fails → Document why, defer standardization**

---

## Phase Governance Status

| Phase | Status | Gate |
|-------|--------|------|
| **Phase 1: Evidence Collection** | ✅ COMPLETE | G1 (Domain Coverage), G2 (Semantic Overlap), G3 (Real Duplication) |
| **Phase 2: Minimum Common Kernel** | ⏳ NEXT | Falsification against adversarial cases |
| **Phase 3: Cost Analysis** | 🔒 PENDING | G4 (Cost Justified) |
| **Phase 4: Migration Feasibility** | 🔒 PENDING | G5 (Migration Feasible) |
| **Phase 5: ADR Creation** | 🔒 PENDING | ADR approval |
| **Phase 6: Bounded Implementation** | 🔒 PENDING | Pilot migration |

---

## Document Status

| Attribute | Value |
|-----------|-------|
| **Phase** | Phase 1: Evidence Collection |
| **Status** | `EVIDENCE COMPLETE — RULE-OF-THREE VALIDATED` |
| **Next Milestone** | Phase 2: Minimum Common Kernel Exploration |
| **Confidence Level** | HIGH (production-validated evidence from 2 frozen kernels) |
| **Recommendation** | Proceed to Phase 2 (bounded kernel exploration with adversarial cases) |
| **ADR Eligibility** | ⏳ PENDING (G4 Cost Analysis + G5 Migration Feasibility required) |
| **Owner** | Human Architect |
| **Last Updated** | 2026-09-09 |

---

## References

- Preschool Capability Discovery: `docs/architecture/PLATFORM_CAPABILITY_DISCOVERY_PRESCHOOL.md`
- Healthcare Kernel: H1-H12 (52 test suites)
- Logistics Kernel: E7.1-E7.3 (547 tests)
- Logistics Evidence Report: Sub-agent output (context above)

---

**IMPORTANT:** 

This document is **Phase 1 Evidence Collection ONLY**. 

**What this document proves:**
- ✅ Universal Lifecycle pattern exists across ≥3 independent domains (Rule-of-Three VALIDATED)
- ✅ Semantic overlap is real (state machines, guards, actor/evidence, terminal states)
- ✅ Real duplication exists (~2100-3950 LOC across 21+ lifecycles)

**What this document does NOT prove:**
- ❌ Abstraction cost < duplication cost (G4 — requires actual abstraction design)
- ❌ Migration is feasible without semantic loss (G5 — requires concrete migration path validation)
- ❌ Abstraction should be built (requires ADR approval after G4/G5 validation)

**Next phase must:**
1. Identify minimum common kernel (bounded exploration)
2. Validate kernel against adversarial cases (Surgical, Prescription, Inventory)
3. Prove abstraction does NOT weaken domain invariants (especially safety-critical guards)

**This is NOT approval to build Universal Lifecycle Engine.**


---

# Phase 2: Minimum Common Kernel Exploration (COMPLETE)

**Date:** 2026-09-09  
**Status:** `FALSIFICATION COMPLETE`  
**Approach:** Adversarial testing against hardest cases  

---

## Objective

> **Có tồn tại một kernel đủ nhỏ để ba lifecycle khó nhất dùng chung mechanism, trong khi toàn bộ domain policy/invariants vẫn thuộc domain không?**

---

## Adversarial Test Cases

### Test Case 1: Surgical Case (Safety-Critical Guards)

**Challenge:** HARD SAFETY BLOCKS (anesthesia consent, WHO checklists, CSSD sterilization)

**Hypothesis:** Kernel provides guard mechanism, domain provides guard policy

**Result:** ⚠️ **PARTIAL PASS**

**What works:**
- ✅ Guards can be domain-defined (Healthcare owns policy)
- ✅ Kernel can enforce ALL guards must pass (mandatory checks)
- ✅ Safety blocks are preserved (guard failure = hard block)
- ✅ Type-safe guard signatures

**What breaks:**
- ❌ Guards are NOT compile-time enforced — Developer can forget to add guards to transition
- ❌ Risk: Abstraction creates weaker execution path than current inline implementation

**Evidence:**
```typescript
// Current implementation (inline guards — cannot forget)
public administerAnesthesia(): void {
  if (!this.props.anesthesiaConsentSigned) {
    throw new Error('Anesthesia Safety Gate: Patient consent must be signed');
  }
  // ... transition
}

// Abstracted implementation (guards in config — can be forgotten)
{
  from: 'PREOP_READY',
  to: 'ANESTHETIZED',
  guards: [], // ❌ Empty array compiles fine but bypasses safety!
}
```

**Critical Risk:** **Compile-time safety for mandatory guards**

---

### Test Case 2: Prescription (Parallel State Machines)

**Challenge:** 3 orthogonal state dimensions (WorkflowStatus, SafetyState, DualVerificationState)

**Hypothesis:** Kernel supports parallel lifecycle composition

**Result:** ❌ **FAIL (Complexity Explosion)**

**What breaks:**
- ❌ 3 dimensions × 7 states × 4 states × 4 states = **112 possible state combinations**
- ❌ Cross-dimension guard explosion (safetyState × verificationState → workflowStatus)
- ❌ Abstraction is MORE complex than current domain code
- ❌ Coupling between dimensions is clearer in current implementation than in cross-guards

**Evidence:**
```typescript
// Current implementation (coupling is explicit)
if (screeningResult.hasBlocking) {
  this.props.safetyState = 'BLOCKED';
  this.props.status = 'REJECTED'; // Clear coupling
}

// Abstracted implementation (coupling hidden in cross-guards)
crossGuards: [
  {
    check(prescription, context) {
      if (prescription.safetyState === 'BLOCKED') {
        return Result.fail('Cannot dispense: safety blocked');
      }
      // ... more complex cross-dimension logic
    }
  }
]
```

**Verdict:** Prescription is **better modeled as single lifecycle with domain-specific state transitions**, NOT as parallel lifecycles.

**Exclusion:** **Parallel state composition NOT INCLUDED in kernel.**

---

### Test Case 3: Inventory (Quantity-Aware Lifecycle)

**Challenge:** Status coupled with quantity (AVAILABLE ↔ RESERVED based on quantityAvailable)

**Hypothesis:** Quantity logic stays in domain, kernel handles status transitions only

**Result:** ✅ **PASS**

**What works:**
- ✅ Kernel provides transition guards (validate preconditions)
- ✅ Domain computes actual status based on quantity
- ✅ Invariant `quantityReserved + quantityAvailable = quantityOnHand` enforced by domain
- ✅ Kernel doesn't need quantity semantics knowledge

**Evidence:**
```typescript
// Domain layer (NOT in kernel)
function reserveInventory(inventory: Inventory, quantity: number): Result<Inventory> {
  // 1. Kernel validates transition is allowed
  const transitionResult = inventoryLifecycle.executeTransition(
    inventory,
    'RESERVED',
    { quantity } // Pass as context, not kernel state
  );
  
  if (transitionResult.isFailure) {
    return transitionResult;
  }
  
  // 2. Domain updates quantities (domain-specific logic)
  const newQuantityReserved = inventory.quantityReserved + quantity;
  const newQuantityAvailable = inventory.quantityOnHand - newQuantityReserved;
  
  // 3. Domain determines actual status (quantity-aware)
  const actualStatus = newQuantityAvailable === 0 ? 'RESERVED' : 'AVAILABLE';
  
  return Result.ok({ ...inventory, status: actualStatus, ... });
}
```

**Verdict:** Quantity-aware logic successfully remains domain-specific. Kernel provides mechanism, domain provides quantity semantics.

---

## Phase 2 Verdict

### Falsification Results

| Test Case | Verdict | Key Finding |
|-----------|---------|-------------|
| **Surgical Case** | ⚠️ PARTIAL | Guards work but compile-time safety is a concern |
| **Prescription** | ❌ FAIL | Parallel lifecycles create complexity explosion |
| **Inventory** | ✅ PASS | Quantity logic successfully stays in domain |

### Overall Assessment

⚠️ **HYPOTHESIS SURVIVES WITH SIGNIFICANT CONSTRAINTS**

**What CAN be abstracted:**
- ✅ State machine definition (states, transitions, terminal states)
- ✅ Guard mechanism (precondition checks before transitions)
- ✅ Authority requirements (who can trigger transitions)
- ✅ Evidence requirements (what proof is needed)
- ✅ Audit trail (temporal provenance tracking)

**What CANNOT be abstracted:**
- ❌ Parallel state composition (too complex, not clearer than domain code)
- ❌ Quantity-aware semantics (domain-specific invariants)
- ❌ Side effects (domain-specific business logic)
- ❌ Event emission logic (domain-specific)
- ❌ Domain-specific transition coupling (e.g., SafetyState → WorkflowStatus)

**Critical Open Issue:**

🔴 **Compile-time safety for mandatory guards**

Current kernel hypothesis allows:
```typescript
guards: [] // Empty guards array — compiles fine but bypasses safety blocks
```

This creates risk that abstraction becomes **weaker execution path** than current inline implementation.

**Mitigation options (not explored in Phase 2):**
- Option A: Runtime validation (not compile-time safe)
- Option B: Type-level enforcement (complex TypeScript gymnastics)
- Option C: Builder pattern with required guards (verbose API)

---

## Refined Minimum Kernel Boundary

Based on falsification, the kernel should be **smaller and more focused** than initial hypothesis:

```typescript
// Minimum Kernel (Mechanism Only)
interface LifecycleKernel<TState, TEntity, TContext> {
  // Core: State machine definition
  states: ReadonlyArray<TState>;
  terminalStates: ReadonlyArray<TState>;
  
  // Core: Transitions with mandatory guard enforcement
  transitions: ReadonlyArray<{
    from: TState;
    to: TState;
    guards: ReadonlyArray<Guard<TEntity, TContext>>;  // ALL must pass
    authority: Authority;                              // WHO can trigger
    evidence: EvidenceRequirement;                     // WHAT proof needed
  }>;
  
  // Core: Execute transition with ALL guards enforced
  executeTransition(
    entity: TEntity,
    toState: TState,
    context: TContext
  ): Result<TEntity>;
}

// Domain owns policy
interface Guard<TEntity, TContext> {
  check(entity: TEntity, context: TContext): Result<void>;
}
```

**Kernel responsibility:** Enforce state machine transitions + mandatory guard checks  
**Domain responsibility:** Define states, guards, authority, evidence, side effects, business logic  

---

## Architectural Decision Point

Phase 2 evidence raises a fundamental question for Human Architect:

> **Bella có thực sự cần một shared lifecycle execution kernel, hay chỉ cần một shared lifecycle contract/specification + validation pattern?**

### Option A: Shared Execution Kernel (Runtime Abstraction)

**Pros:**
- Standardized lifecycle behavior across all domains
- Centralized guard enforcement
- Reduced duplication (~2100-3950 LOC)

**Cons:**
- 🔴 Risk of weaker execution path (compile-time safety concern)
- 🔴 Safety-critical behavior moves to shared runtime
- 🔴 Complex API design to maintain safety guarantees

### Option B: Shared Contract/Specification (Design Pattern)

**Pros:**
- ✅ Standardized lifecycle semantics without runtime abstraction
- ✅ Domain retains full control over execution (safety-critical code stays inline)
- ✅ Compile-time safety preserved (current implementation stays)
- ✅ Validation/audit patterns can still be shared

**Cons:**
- Some duplication remains (but safety-critical code should arguably be explicit)

### Option C: Hybrid Approach

**Pros:**
- Shared kernel for non-critical lifecycles (Bed Status, Item Status, Location Status)
- Inline implementation for safety-critical lifecycles (Surgical Case, Prescription)
- Balance between standardization and safety

**Cons:**
- Two patterns coexist (added complexity)
- Need clear criteria for when to use kernel vs. inline

---

## Phase 2 Closure Status

| Attribute | Value |
|-----------|-------|
| **Phase** | Phase 2: Minimum Common Kernel Exploration |
| **Status** | `FALSIFICATION COMPLETE` |
| **Hypothesis** | ⚠️ SURVIVES WITH CONSTRAINTS |
| **Critical Risk** | Compile-time safety for mandatory guards |
| **Exclusions Identified** | Parallel state composition, quantity-aware semantics |
| **Next Decision** | Human Architect: Execution Kernel vs. Contract/Specification |
| **G4 (Cost Analysis)** | ⏳ PENDING (blocked on architectural direction decision) |
| **G5 (Migration Feasibility)** | ⏳ PENDING (blocked on architectural direction decision) |
| **ADR Eligibility** | ⏳ PENDING (blocked on architectural direction decision) |

---

## Recommendation for Human Architect

**Do NOT proceed to G4/G5 until architectural direction is clear.**

**Decision Required:**
1. **Shared Execution Kernel** → Need to solve compile-time safety issue first (refine API)
2. **Shared Contract/Specification** → Skip G4/G5, document pattern instead of building engine
3. **Hybrid Approach** → Define criteria for kernel vs. inline, then proceed with non-critical lifecycles only

**Evidence Sufficiency:** ✅ **SUFFICIENT FOR DECISION**

Phase 2 has provided:
- ✅ Proof that minimal kernel CAN express diverse lifecycles (Surgical, Inventory)
- ✅ Proof that some patterns should NOT be abstracted (Prescription parallel states)
- ✅ Clear identification of critical risk (compile-time safety)
- ✅ Clear boundary between mechanism (kernel) and policy (domain)

**No further exploration needed until architectural direction is chosen.**

---

## Final Phase 2 Verdict

```
UNIVERSAL LIFECYCLE — PHASE 2 COMPLETE
────────────────────────────────────────

Rule-of-Three                       ✅ VALIDATED (Phase 1)
Minimum Kernel Boundary             ✅ IDENTIFIED (Phase 2)
Compile-Time Safety                 🔴 OPEN ISSUE
Parallel State Composition          ❌ EXCLUDED
Quantity-Aware Semantics            ❌ DOMAIN-OWNED
Safety-Critical Guards              ⚠️ RISKY in abstraction

Hypothesis Status:                  ⚠️ SURVIVES WITH CONSTRAINTS
Evidence Quality:                   HIGH (falsification-tested)
Architectural Decision Required:    Execution Kernel vs. Contract/Specification

Next Phase:                         🔒 BLOCKED until direction chosen
```

**Phase 2 is CLOSED. Awaiting Human Architect decision before proceeding to G4/G5.**

